Maravai Lifesciences Holdings (MRVI) FCF Payout Ratio (2020 - 2024)

Maravai Lifesciences Holdings' FCF Payout Ratio history runs 5 years deep, the most recent figure standing at 0.0 for Q4 2024.

• In Q4 2024, FCF Payout Ratio changed N/A year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.01 (up 83.54% YoY), while the FY2024 annual figure was 0.02, down 114.06% from the prior year.
• FCF Payout Ratio was 0.0 for Q4 2024 at Maravai Lifesciences Holdings, down from 0.11 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.91 in Q4 2021 to a low of 0.0 in Q3 2020.
• Historically, FCF Payout Ratio has averaged 0.39 across 5 years, with a median of 0.25 in 2022.
• The sharpest annual moves came in 2021 and 2022: FCF Payout Ratio soared 19136.63% in 2021, then slumped 80.78% in 2022.
• A 5-year view of FCF Payout Ratio shows it stood at 1.17 in 2020, then jumped by 63.47% to 1.91 in 2021, then plunged by 80.78% to 0.37 in 2022, then slumped by 85.4% to 0.05 in 2023, then tumbled by 92.91% to 0.0 in 2024.
• The last three FCF Payout Ratio figures came in at 0.0 (Q4 2024), 0.11 (Q2 2024), and 0.05 (Q2 2023), per Business Quant data.